BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28439702)

  • 21. Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
    Weitz JI; Segers A; Raskob G; Roberts RS; Francis C; Lassen MR; Fuji T; Swaim RM; Lee M; Peters G; DiBattiste PM; Tesfaye F; Strony J
    J Thromb Haemost; 2019 Dec; 17(12):2081-2088. PubMed ID: 31529590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty.
    Mommsen P; Doering M; R O Hrs E; Egidy C; Gehrke T; Krettek C; Kendoff D
    Technol Health Care; 2014; 22(6):901-8. PubMed ID: 25318954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery.
    Eriksson BI; Mikuska Z; Feuring M; Amiral J; Haertter S; Stangier J; Nehmiz G; Weitz JI
    Thromb Res; 2016 Aug; 144():158-64. PubMed ID: 27352238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
    Eriksson BI; Dahl OE; Rosencher N; Kurth AA; van Dijk CN; Frostick SP; Prins MH; Hettiarachchi R; Hantel S; Schnee J; Büller HR;
    Lancet; 2007 Sep; 370(9591):949-56. PubMed ID: 17869635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wound problems following hip arthroplasty before and after the introduction of a direct thrombin inhibitor for thromboprophylaxis.
    Gill SK; Theodorides A; Smith N; Maguire E; Whitehouse SL; Rigby MC; Ivory JP
    Hip Int; 2011; 21(6):678-83. PubMed ID: 22117258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
    Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
    J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apixaban: a review of its use in the prevention of venous thromboembolism after knee or hip replacement surgery.
    Deeks ED
    Drugs; 2012 Jun; 72(9):1271-91. PubMed ID: 22686618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
    Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
    Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Portman RJ
    N Engl J Med; 2009 Aug; 361(6):594-604. PubMed ID: 19657123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
    Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty.
    Russell RD; Huo MH
    J Arthroplasty; 2013 Oct; 28(9):1477-81. PubMed ID: 23540535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacologic heterogeneity of new anticoagulants].
    Samamaa MM; Conard J; Flaujac C; Combe S; Horellou MH
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S10-5. PubMed ID: 22177763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.
    Eriksson BI; Dahl OE; Ahnfelt L; Kälebo P; Stangier J; Nehmiz G; Hermansson K; Kohlbrenner V
    J Thromb Haemost; 2004 Sep; 2(9):1573-80. PubMed ID: 15333033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).
    Barequet IS; Zehavi-Dorin T; Bourla N; Tamarin I; Moisseiev J; Salomon O
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2671-2676. PubMed ID: 31641883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
    Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Hornick P;
    Lancet; 2010 Mar; 375(9717):807-15. PubMed ID: 20206776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
    Suen K; Westh RN; Churilov L; Hardidge AJ
    J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis.
    Cai JY; Cui CM; Min JK; Cao YQ; Zhang LY
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6245-6259. PubMed ID: 34730204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacement.
    Lassen MR
    Drugs Today (Barc); 2012 Apr; 48(4):249-58. PubMed ID: 22536567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.